Investing.com - UBS has lowered its price target on Neurocrine Biosciences (NASDAQ:NBIX) to $188.00 from $195.00 while maintaining a Buy rating on the stock. Currently trading at $137.42, Neurocrine ...

Upslope Capital delivered a 14.8% net return in FY 2025, significantly outperforming the S&P Midcap 400 with reduced ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Thibault Spirlet Every time Thibault publishes a story, you’ll get an alert straight to your ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Membership (fee-based) Forbes Technology Council is an invitation-only, fee-based ...

The first part of Ottawa’s strategy to boost biofuels and shore up domestic demand for canola came into force on Jan 1. The $370-million Biofuel Production Incentive will be given to biofuel producers ...

An office boy at Biograph learns how to operate a camera, and when he spies the boss kissing his secretary, he records their illicit act.